James Alan Muns, MD | |
2737 S Broadway Ave, Tyler, TX 75701-5413 | |
(903) 592-6000 | |
(903) 592-3224 |
Full Name | James Alan Muns |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 9 Years |
Location | 2737 S Broadway Ave, Tyler, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023276466 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | Q0126 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Encompass Home Health Of East Texas | Longview, TX | Home health agency |
Encompass Home Health Of East Texas | Nacogdoches, TX | Home health agency |
Christus Good Shepherd Medical Center | Longview, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Christus Trinity Clinic | 3072426741 | 1227 |
News Archive
Measuring antibody levels in the blood could be used to detect a person's heart attack risk after researchers, part-funded by the British Heart Foundation, discovered that higher levels of these antibodies are linked to a lower heart attack risk.
Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding its RIGScan technology Biologic License Application (BLA).
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research.
Australian laws need to change to allow women carrying mitochondrial disease to access a ground-breaking IVF procedure so they can have healthy, biologically-related children free from this incurable and life-threatening genetic disease, according to the Australian Mitochondrial Disease Foundation.
› Verified 4 days ago
Entity Name | Christus Trinity Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
Measuring antibody levels in the blood could be used to detect a person's heart attack risk after researchers, part-funded by the British Heart Foundation, discovered that higher levels of these antibodies are linked to a lower heart attack risk.
Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding its RIGScan technology Biologic License Application (BLA).
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research.
Australian laws need to change to allow women carrying mitochondrial disease to access a ground-breaking IVF procedure so they can have healthy, biologically-related children free from this incurable and life-threatening genetic disease, according to the Australian Mitochondrial Disease Foundation.
› Verified 4 days ago
Entity Name | Charles R. Gordon., Md, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982717955 PECOS PAC ID: 8729992052 Enrollment ID: O20031206000131 |
News Archive
Measuring antibody levels in the blood could be used to detect a person's heart attack risk after researchers, part-funded by the British Heart Foundation, discovered that higher levels of these antibodies are linked to a lower heart attack risk.
Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding its RIGScan technology Biologic License Application (BLA).
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research.
Australian laws need to change to allow women carrying mitochondrial disease to access a ground-breaking IVF procedure so they can have healthy, biologically-related children free from this incurable and life-threatening genetic disease, according to the Australian Mitochondrial Disease Foundation.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
James Alan Muns, MD Po Box 6605, Tyler, TX 75711-6605 Ph: (903) 592-6000 | James Alan Muns, MD 2737 S Broadway Ave, Tyler, TX 75701-5413 Ph: (903) 592-6000 |
News Archive
Measuring antibody levels in the blood could be used to detect a person's heart attack risk after researchers, part-funded by the British Heart Foundation, discovered that higher levels of these antibodies are linked to a lower heart attack risk.
Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding its RIGScan technology Biologic License Application (BLA).
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research.
Australian laws need to change to allow women carrying mitochondrial disease to access a ground-breaking IVF procedure so they can have healthy, biologically-related children free from this incurable and life-threatening genetic disease, according to the Australian Mitochondrial Disease Foundation.
› Verified 4 days ago
Dr. Mark B Renfro, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Olympic Plaza Cir, Ste 850, Tyler, TX 75701 Phone: 903-595-2441 Fax: 903-595-0743 | |
Dr. Jon T Ledlie, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 700 Olympic Plaza Cir, Ste 850, Tyler, TX 75701 Phone: 903-595-2441 Fax: 903-595-0743 | |
Charles R Gordon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2737 S Broadway Ave, Tyler, TX 75701 Phone: 903-592-6000 Fax: 903-592-3224 | |
James E Wortham, P.A. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2737 S Broadway Ave, Tyler, TX 75701 Phone: 903-592-6000 Fax: 903-592-3224 | |
Dr. Paul W Detwiler, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Olympic Plaza Cir, Ste 850, Tyler, TX 75701 Phone: 903-595-2441 Fax: 903-595-0743 | |
Dr. Nicholas Stephen Andrade, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Olympic Plaza Cir Ste 850, Tyler, TX 75701 Phone: 903-590-8012 |